From Genome to Disease: 
         A Symposium of High Throughput Biology

Updated: 10/01/2004

Donors to this symposium helped bring together investigators from around the world to discuss advances in genetics, genomics, and proteomics technologies, particularly as they are applied to the study of human diseases and to educate investigators about the potential application of high throughput genomic and proteomic methods and resources in their own work. 

Affymetrix, Inc.
The American Physiological Society
Amersham Biosciences
Applied Biosystems
Charles River Laboratories
Genetix
Glen Research Corporation
Invitrogen Corporation
Lexicon Genetics Incorporated
Merck & Co., Inc.
The Midland Certified Reagent Co., Inc.
Novartis Pharmaceuticals Corporation
PerkinElmer Instruments
Promega Corporation
Qiagen, Inc.
Roche Applied Science
Sequenom, Inc.
Stratagene
Union Biometrica, Inc.

Donors who contributed between January 1 and December 31, 2003 are listed above. If we have erred in spelling or listing your name, please contact the Foundation at 301-402-5311 so that we can correct our records.